메뉴 건너뛰기




Volumn 16, Issue 1, 2002, Pages 5-11

Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors

Author keywords

ACE inhibitors; Obesity; Sibutramine; Weight loss

Indexed keywords

BENAZEPRIL; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LISINOPRIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SIBUTRAMINE; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL; URIC ACID; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

EID: 85047697192     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001298     Document Type: Article
Times cited : (105)

References (19)
  • 1
    • 0030705157 scopus 로고    scopus 로고
    • Obesity and heart disease. A statement for healthcare professionals from the Nutrition Committee, American Heart Association
    • (1997) Circulation , vol.96 , pp. 3248-3250
    • Eckel, R.H.1
  • 2
    • 0029032610 scopus 로고
    • Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men
    • (1995) Am J Epidemiol , vol.141 , pp. 1117-1127
    • Rimm, E.B.1
  • 4
    • 0033533859 scopus 로고    scopus 로고
    • Body-mass index and mortality in a prospective cohort of U.S. adults
    • (1999) N Engl J Med , vol.341 , pp. 1097-1105
    • Calle, E.E.1
  • 5
    • 0032575852 scopus 로고    scopus 로고
    • Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults
    • (1998) Arch Intern Med , vol.158 , pp. 1855-1867
  • 6
    • 0033090465 scopus 로고    scopus 로고
    • Sibutramine produces dose-related weight loss
    • (1999) Obes Res , vol.7 , pp. 189-198
    • Bray, G.A.1
  • 7
    • 0034516930 scopus 로고    scopus 로고
    • Effect of sibutramine on weight maintenance after weight loss: A randomised trial
    • (2000) Lancet , vol.356 , pp. 2119-2125
    • James, W.P.T.1
  • 9
    • 0032474427 scopus 로고    scopus 로고
    • American Heart Association call to action: Obesity as a major risk factor for coronary heart disease
    • (1998) Circulation , vol.97 , pp. 2099-2100
    • Eckel, R.H.1    Krauss, R.M.2
  • 11
    • 0030713021 scopus 로고    scopus 로고
    • The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    • (1997) Arch Intern Med , vol.157 , pp. 2413-2446
  • 13
    • 0033082197 scopus 로고    scopus 로고
    • Long-term maintenance of weight loss after a very-low-calorie diet: A randomized blinded trial of the efficacy and tolerability of sibutramine
    • (1999) Am J Med , vol.106 , pp. 179-184
    • Apfelbaum, M.1
  • 14
    • 0032974273 scopus 로고    scopus 로고
    • The Hypertension Optimal Treatment study and the importance of lowering blood pressure
    • (1999) J Hypertens , vol.17 , pp. S9-S13
    • Hansson, L.1
  • 15
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
    • (1998) Lancet , vol.351 , pp. 1755-1762
    • Hansson, L.1
  • 16
    • 0034095342 scopus 로고    scopus 로고
    • One-year treatment of obesity: A randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor
    • (2000) Int J Obes , vol.24 , pp. 306-313
    • Finer, N.1
  • 17
    • 0034522392 scopus 로고    scopus 로고
    • Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus
    • (2000) Diabetes Obes Metab , vol.2 , pp. 175-187
    • Fujioka, K.1
  • 18
    • 4243658955 scopus 로고    scopus 로고
    • Framingham analysis: Coronary heart disease risk reduction with weight loss in obesity on sibutramine treatment
    • [abstract PB 83]
    • (2000) Obes Res , vol.8 , pp. 88S
    • Lauterbach, K.1    Evers, T.2
  • 19
    • 0034710218 scopus 로고    scopus 로고
    • Efficacy and safety of sibutramine in obese white and African American patients with hypertension: A 1-year, double-blind, placebo-controlled, multicenter trial
    • (2000) Arch Intern Med , vol.160 , pp. 2185-2191
    • McMahon, F.G.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.